A detailed history of Panagora Asset Management Inc transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Panagora Asset Management Inc holds 102,029 shares of PBYI stock, worth $327,513. This represents 0.0% of its overall portfolio holdings.

Number of Shares
102,029
Previous 102,820 0.77%
Holding current value
$327,513
Previous $335,000 22.39%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$2.25 - $4.03 $1,779 - $3,187
-791 Reduced 0.77%
102,029 $260,000
Q2 2024

Jul 29, 2024

BUY
$2.92 - $5.83 $300,234 - $599,440
102,820 New
102,820 $335,000
Q2 2022

Aug 15, 2022

SELL
$1.64 - $3.3 $336,426 - $676,955
-205,138 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$2.13 - $3.24 $15,050 - $22,893
7,066 Added 3.57%
205,138 $591,000
Q4 2021

Feb 10, 2022

BUY
$2.85 - $6.58 $6,435 - $14,857
2,258 Added 1.15%
198,072 $602,000
Q3 2021

Nov 10, 2021

SELL
$6.63 - $9.39 $39,203 - $55,523
-5,913 Reduced 2.93%
195,814 $1.37 Million
Q2 2021

Aug 11, 2021

SELL
$8.98 - $11.6 $125,791 - $162,492
-14,008 Reduced 6.49%
201,727 $1.85 Million
Q1 2021

May 12, 2021

SELL
$9.38 - $13.63 $51,665 - $75,074
-5,508 Reduced 2.49%
215,735 $2.1 Million
Q4 2020

Feb 10, 2021

SELL
$7.78 - $12.13 $564,182 - $879,631
-72,517 Reduced 24.69%
221,243 $2.27 Million
Q3 2020

Nov 13, 2020

SELL
$9.5 - $11.14 $21,878 - $25,655
-2,303 Reduced 0.78%
293,760 $2.96 Million
Q2 2020

Aug 12, 2020

BUY
$7.01 - $13.24 $1.03 Million - $1.95 Million
146,974 Added 98.58%
296,063 $3.09 Million
Q1 2020

May 14, 2020

BUY
$6.28 - $14.57 $568,415 - $1.32 Million
90,512 Added 154.52%
149,089 $1.26 Million
Q4 2019

Feb 12, 2020

BUY
$6.5 - $10.73 $18,063 - $29,818
2,779 Added 4.98%
58,577 $513,000
Q2 2019

Aug 09, 2019

BUY
$12.3 - $35.76 $686,315 - $2 Million
55,798 New
55,798 $709,000
Q4 2018

Feb 14, 2019

SELL
$20.07 - $46.7 $90,876 - $211,457
-4,528 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$41.2 - $59.85 $1.47 Million - $2.14 Million
-35,782 Reduced 88.77%
4,528 $208,000
Q2 2018

Aug 14, 2018

BUY
$48.3 - $68.25 $491,017 - $693,829
10,166 Added 33.72%
40,310 $2.38 Million
Q1 2018

May 15, 2018

BUY
$59.7 - $99.25 $126,922 - $211,005
2,126 Added 7.59%
30,144 $2.05 Million
Q4 2017

Feb 14, 2018

BUY
$93.85 - $132.45 $2.63 Million - $3.71 Million
28,018
28,018 $2.77 Million

Others Institutions Holding PBYI

About PUMA BIOTECHNOLOGY, INC.


  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $146M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.